Financhill
Buy
64

CASH Quote, Financials, Valuation and Earnings

Last price:
$95.71
Seasonality move :
1.64%
Day range:
$93.13 - $96.06
52-week range:
$64.45 - $96.06
Dividend yield:
0.21%
P/E ratio:
11.65x
P/S ratio:
2.62x
P/B ratio:
2.44x
Volume:
216K
Avg. volume:
287.1K
1-year change:
19.86%
Market cap:
$2.1B
Revenue:
$836.4M
EPS (TTM):
$8.22

Analysts' Opinion

  • Consensus Rating
    Pathward Financial, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $100.00, Pathward Financial, Inc. has an estimated upside of 4.48% from its current price of $95.71.
  • Price Target Downside
    According to analysts, the lowest downside price target is $100.00 representing 100% downside risk from its current price of $95.71.

Fair Value

  • According to the consensus of 2 analysts, Pathward Financial, Inc. has 4.48% upside to fair value with a price target of $100.00 per share.

CASH vs. S&P 500

  • Over the past 5 trading days, Pathward Financial, Inc. has overperformed the S&P 500 by 7.23% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Pathward Financial, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Pathward Financial, Inc. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Pathward Financial, Inc. reported revenues of $175M.

Earnings Growth

  • Pathward Financial, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Pathward Financial, Inc. reported earnings per share of $1.57.
Enterprise value:
2.1B
EV / Invested capital:
2.35x
Price / LTM sales:
2.62x
EV / EBIT:
8.92x
EV / Revenue:
2.54x
PEG ratio (5yr expected):
0.73x
EV / Free cash flow:
5.07x
Price / Operating cash flow:
5.23x
Enterprise value / EBITDA:
141.25x
Gross Profit (TTM):
--
Return On Assets:
2.62%
Net Income Margin (TTM):
22.74%
Return On Equity:
23.35%
Return On Invested Capital:
21.22%
Operating Margin:
24.38%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $742M $810.4M $842.1M $169.3M $175M
Gross Profit -- -- -- -- --
Operating Income $193.2M $198.5M $236.8M $19.8M $42.7M
EBITDA -- -- -- $55.9M $57.9M
Diluted EPS $6.37 $7.09 $8.22 $1.23 $1.57
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $1.3B $389.3M $698.7M $632.7M $367.4M
Total Assets $7.6B $6.7B $7.9B $7.6B $7.6B
Current Liabilities $6.3B $5.6B $6.6B $6.3B $6.1B
Total Liabilities $6.8B $6B $7.2B $6.8B $6.7B
Total Equity $826.2M $659.1M $729.3M $757.6M $853.7M
Total Debt $123.5M $63.2M $59.1M $54.6M $54.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $290.3M $387.5M $630.7M -$71.7M $108.3M
Cash From Investing -$1B $80.5M -$567.3M $292.8M -$300.4M
Cash From Financing $1B -$539.8M -$331.2M $220.1M $401.9M
Free Cash Flow -$101.4M $164M $421.9M -$126.6M $58.7M
CASH
Sector
Market Cap
$2.1B
$550.3M
Price % of 52-Week High
99.64%
91.53%
Dividend Yield
0.21%
1.43%
Shareholder Yield
14.75%
2.97%
1-Year Price Total Return
19.86%
9.09%
Beta (5-Year)
0.754
0.446
Dividend yield:
0.21%
Annualized payout:
$0.20
Payout ratio:
3.19%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $92.43
200-day SMA
Buy
Level $77.10
Bollinger Bands (100)
Buy
Level 68.12 - 83.96
Chaikin Money Flow
Buy
Level 497.6K
20-day SMA
Buy
Level $90.80
Relative Strength Index (RSI14)
Buy
Level 72.10
ADX Line
Sell
Level 26.51
Williams %R
Sell
Level -2.3131
50-day SMA
Buy
Level $80.90
MACD (12, 26)
Buy
Level 21.04
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Neutral
Level 2.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.4958)
Sell
CA Score (Annual)
Level (-2.0482)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (4)
Sell
Ohlson Score
Level (5.9069)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Pathward Financial, Inc. is a financial holding company, which provides savings and loan services. The firm operates through the following business segments: Consumer, Commercial, and Corporate Services/Other. The Consumer segment collaborates with partners to navigate payment and lending needs. The Commercial segment refers to the commercial finance business line, which helps businesses access funds they need to launch, operate, and grow. The Corporate Services/Other segment consists of certain shared services, treasury, retained community bank portfolio, and student loan lending. The company was founded on June 14, 1993 and is headquartered in Sioux Falls, SD.

Stock Forecast FAQ

In the current month, CASH has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The CASH average analyst price target in the past 3 months is $100.00.

  • Where Will Pathward Financial, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Pathward Financial, Inc. share price will rise to $100.00 per share over the next 12 months.

  • What Do Analysts Say About Pathward Financial, Inc.?

    Analysts are divided on their view about Pathward Financial, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Pathward Financial, Inc. is a Sell and believe this share price will drop from its current level to $100.00.

  • What Is Pathward Financial, Inc.'s Price Target?

    The price target for Pathward Financial, Inc. over the next 1-year time period is forecast to be $100.00 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.

  • Is CASH A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Pathward Financial, Inc. is a Hold. 2 of 2 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CASH?

    You can purchase shares of Pathward Financial, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Pathward Financial, Inc. shares.

  • What Is The Pathward Financial, Inc. Share Price Today?

    Pathward Financial, Inc. was last trading at $95.71 per share. This represents the most recent stock quote for Pathward Financial, Inc.. Yesterday, Pathward Financial, Inc. closed at $95.71 per share.

  • How To Buy Pathward Financial, Inc. Stock Online?

    In order to purchase Pathward Financial, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 23

RingCentral, Inc. [RNG] is down 8.66% over the past day.

Sell
9
FROG alert for Feb 23

JFrog Ltd. [FROG] is down 2.94% over the past day.

Buy
72
SNSE alert for Feb 23

Sensei Biotherapeutics, Inc. [SNSE] is down 5.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock